Tag: Women in Medicine
-
Northwestern Celebrates Women in Medicine
Feinberg celebrates the remarkable achievements of Northwestern’s women faculty in medicine and commemorates their contributions to science, clinical medicine, and society.
-
Lerner Receives NIH New Innovator Award
Talia Lerner, PhD, has received the NIH Director’s New Innovator Award, an early-career grant supporting projects in the biomedical, behavioral or social sciences.
-
New Center for Food Allergy and Asthma Research Established
Northwestern has established the new Center for Food Allergy and Asthma Research, which will provide investigators and patients more support while uncovering new discoveries from applied and basic science research on allergies.
-
Stopping Gunshot Deaths from the Trauma Bay and Beyond with Mamta Swaroop, MD
In 2017, Mamta Swaroop, MD, decided it was time to empower Chicago communities by training bystanders to be immediate responders. In this audio essay, she shares her story.
-
Yanez Honored for Work in Psychosocial Oncology
Betina Yanez, PhD, received the New Investigator Award 2019 from the American Psychosocial Oncology Society.
-
Women’s Health Research Day Celebrates Sex-Inclusive Science
Northwestern scientists came together to discuss the importance of women’s health research and mark the third anniversary of a landmark sex-inclusion policy by the NIH.
-
Study Suggests New Strategy to Treat Advanced Prostate Cancer
A Northwestern Medicine study provides new insights into a signaling pathway in metastatic prostate cancer and suggests that a novel drug combination may improve treatment response and slow cancer growth.
-
McNally Elected to National Academy of Inventors
Elizabeth McNally, MD, PhD, has been elected as a fellow of the National Academy of Inventors, joining more than 900 other inventors, who were selected for prolific innovations that improve quality of life or economic development.
-
Drug Regimen Improves Survival in Lymphoma
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
